Furthermore, NVS-ZP7-4 inhibited the activation of PI3K/AKT signaling, and in vivo, NVS-ZP7-4 treatment of HCC in nude mice resulted in decreased tumor weight and expression of PCAN, p-AKT, and increased cleaved caspase-3. This evidence concerns the gene PODN and hepatocellular carcinoma.